Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride both increase chromogranin A levels similarly.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Finasteride may affect male fertility by interfering with specific sperm signaling.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The journal retracted an article due to inaccurate statistics and asked the authors to revise and resubmit it.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Male pattern baldness may be linked to prostate cancer risk.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.